C57BL/6JCya-Cog5em1/Cya
Common Name
Cog5-KO
Product ID
S-KO-06949
Backgroud
C57BL/6JCya
Strain ID
KOCMP-238123-Cog5-B6J-VA
When using this mouse strain in a publication, please cite “Cog5-KO Mouse (Catalog S-KO-06949) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Cog5-KO
Strain ID
KOCMP-238123-Cog5-B6J-VA
Gene Name
Product ID
S-KO-06949
Gene Alias
GTC90, GOLTC1, 5430405C01Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 12
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000036862
NCBI RefSeq
NM_001163126.1
Target Region
Exon 2~5
Size of Effective Region
~10.1 kb
Overview of Gene Research
COG5 is a component of the Conserved Oligomeric Golgi (COG) complex, which facilitates retrograde Golgi trafficking. Disruptions in COG5 can lead to protein misfolding. The COG complex, along with SNARE and Sec1/Munc18 (SM) proteins, is required for vesicle docking and fusion at the Golgi, playing a crucial role in maintaining cellular protein homeostasis [4].
COG5 variants have been associated with multiple disorders. In patients with Leber congenital amaurosis (LCA), COG5 compound-heterozygous variants can result in a complex LCA phenotype with microcephaly and skeletal dysplasia. These variants lead to fragmentation of the Golgi apparatus, upregulation of the UPR modulator PKR-like endoplasmic reticulum kinase (PERK), and induction of DNA damage in cultured cells and murine retina [1]. Mutations in COG5 are also related to a distinct congenital disorder of glycosylation (type IIi), where missense variants can alter protein solubility and stability, disrupt the COG5-COG7 interaction, and lead to a broad clinical spectrum from mild to severe phenotypes [2,3].
In conclusion, COG5 is essential for retrograde Golgi trafficking and maintaining ER protein homeostasis. Studies on COG5-related disorders, including LCA and congenital disorders of glycosylation, highlight its importance in these disease conditions. Understanding the role of COG5 through model-based research, such as in murine retina experiments, provides insights into the underlying molecular mechanisms of these diseases.
References:
1. Tabbarah, Sami, Tavares, Erika, Charish, Jason, Heon, Elise, Monnier, Philippe P. 2020. COG5 variants lead to complex early onset retinal degeneration, upregulation of PERK and DNA damage. In Scientific reports, 10, 21269. doi:10.1038/s41598-020-77394-3. https://pubmed.ncbi.nlm.nih.gov/33277529/
2. Khabou, Boudour, Sahari, Umar Bin Mohamad, Ben Issa, Abir, Reversade, Bruno, Charfi Triki, Chahnez. 2024. Characterization of a missense variant in COG5 in a Tunisian patient with COG5-CDG syndrome and insights into the effect of non-synonymous variants on COG5 protein. In Journal of human genetics, 69, 591-597. doi:10.1038/s10038-024-01273-2. https://pubmed.ncbi.nlm.nih.gov/38987656/
3. Rymen, Daisy, Keldermans, Liesbeth, Race, Valérie, Matthijs, Gert, Jaeken, Jaak. 2012. COG5-CDG: expanding the clinical spectrum. In Orphanet journal of rare diseases, 7, 94. doi:10.1186/1750-1172-7-94. https://pubmed.ncbi.nlm.nih.gov/23228021/
4. Ha, Jun Yong, Pokrovskaya, Irina D, Climer, Leslie K, Lupashin, Vladimir V, Hughson, Frederick M. 2014. Cog5-Cog7 crystal structure reveals interactions essential for the function of a multisubunit tethering complex. In Proceedings of the National Academy of Sciences of the United States of America, 111, 15762-7. doi:10.1073/pnas.1414829111. https://pubmed.ncbi.nlm.nih.gov/25331899/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
